News
Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...
2h
Zacks Investment Research on MSNNovo Nordisk Shares Dip 3% on Sudden CEO Transition AnnouncementNovo Nordisk A/S NVO shares lost 2.7% on Friday after a surprising announcement regarding changes to its executive leadership ...
HONG KONG – Asian shares fell Monday and U.S. futures and the dollar weakened after Moody’sRatings downgraded the sovereign ...
U.S. stocks are set to wrap a winning week as tariff and trade fears ease, President Trump winds down his Middle East trip securing billions of investments for the U.S. and Warren Buffett’s Berkshire ...
Wall Street cruised to the finish of its strong week on Friday, as U.S. stocks glided closer to the all-time high they set ...
Lars Fruergaard Jorgensen, who has headed the pharmaceutical company for eight years, will step down after a period to ...
On Wall Street, Charter Communications rose 1.8% after it said it agreed to merge with Cox Communications in a deal that ...
In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...
Novo Nordisk A/S' CEO transition sparks governance concerns, but internal succession ensures stability. Click for my updated ...
Health-care companies rose sharply, recouping some losses from earlier in the week. UnitedHealth Group recouped 6% on Friday, but still lost almost one quarter of its value for the week after the ...
FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results